Advanced search
Publication Cover
Scandinavian Journal of Rheumatology Volume 39, 2010 - Issue 5
Submit an article Journal homepage
53
Views
0
CrossRef citations to date
0
Altmetric
Letters

Differences in utility and other disease severity levels in patients with rheumatoid arthritis from three European countries

T Uhlig Department of Rheumatology, Diakonhjemmet Hospital, Oslo, NorwayCorrespondence[email protected]
,
W Lems Department of Rheumatology, VU University Medical Centre, Amsterdam, The Netherlands
,
BAC Dijkmans Department of Rheumatology, VU University Medical Centre, Amsterdam, The Netherlands
,
TK Kvien Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway
,
AD Woolf Department of Rheumatology, Royal Cornwall Hospital, Truro, UK
&
OSTRA group Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway
Pages 433-434 | Accepted 16 Mar 2010, Published online: 21 Jun 2010

References

  • Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137–45.
  • Ware JE Jr, Kosinski M, Keller SD. SF-36 physical and mental health summary scales: a user’s manual. Boston MA: The Health Institute, New England Medical Center, 1994.
  • Lodder MC, Haugeberg G, Lems WF, Uhlig T, Orstavik RE, Kostense PJ, Radiographic damage associated with low bone mineral density and vertebral deformities in rheumatoid arthritis: the Oslo-Truro-Amsterdam (OSTRA) collaborative study. Arthritis Rheum 2003;49:209–15.
  • Hurst NP, Kind P, Ruta D, Hunter M, Stubbings A. Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D). Br J Rheumatol 1997;36:551–9.
  • Horsman J, Furlong W, Feeny D, Torrance G. The Health Utilities Index (HUI): concepts, measurement properties and applications. Health Qual Life Outcomes 2003;1:54.
  • Marra CA, Woolcott JC, Kopec JA, Shojania K, Offer R, Brazier JE, A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Soc Sci Med 2005;60:1571–82.
  • Uhlig T, Loge JH, Kristiansen IS, Kvien TK. Quantification of reduced health-related quality of life in patients with rheumatoid arthritis compared to the general population. J Rheumatol 2007;34:1241–7.
  • Drummond M. Pharmacoeconomics: friend or foe? Ann Rheum Dis 2006;65(Suppl 3):iii44–7.
  • Sokka T, Kautiainen H, Pincus T, Toloza S, Castelar Pinheiro GD, Lazovskis J, Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST-RA database. Ann Rheum Dis 2009;68:1666–72.
  • Emery P, Van VR, Ostergaard M, Choy E, Combe B, Graninger W, Guidelines for initiation of anti-tumour necrosis factor therapy in rheumatoid arthritis: similarities and differences across Europe. Ann Rheum Dis 2009;68:456–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.